Dermatomyositis: clinical features
Evidence-based neurology checklist on dermatomyositis: clinical features: Possible risk factors Exposure to ultraviolet light TIF1 gene mutations Some class 2 HLA alleles Major dermatological features Other dermatological features Neurological features Oral features Anti-MDA5 features Associated…
Possible risk factors
- Exposure to ultraviolet light
- TIF1 gene mutations
- Some class 2 HLA alleles
Major dermatological features
Other dermatological features
Neurological features
Oral features
Anti-MDA5 features
Associated disorders
References
- Dalakas MC. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Ther Adv Neurol Disord 2008; 1:157-166.
- Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 2010; 1184:134-153.
- Amato AA, Barohn RJ. Evaluation and treatment of inflammatory myopathies. JNNP 2009; 80:1060-1068.
- Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol 2018; 17:816-828.
- Marvi U, Chung L, Fiorentino D. Clinical presentation and evaluation of dermatomyositis. Indian J Dermatol 2012; 57:375-381.
- And 10 more. Subscribe to see the full list
